Table 1 General participant characteristics (means ± SD).
From: Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
Recovered SARS patients (n = 25) | Healthy volunteers (n = 25) | P | |
|---|---|---|---|
Male/female (n) | 5/20 | 5/20 | |
Age (years) | 47 ± 12 | 47 ± 11 | 0.486 |
Body weight (kg) | 67 ± 13 | 63 ± 12 | 0.107 |
BMI (kg/m2) | 24 ± 3 | 24 ± 4 | 0.230 |
Smoking | 0 | 8% | |
Alcohol drinking | 0 | 8% | |
Methylprednisolone (mg) | 5454 ± 3153 | 0 | |
Duration of treatment (days) | 36 ± 7 | 0 | |
Max. daily pulse (mg) | 381 ± 306 | 0 | |
Hospitalization since recovery (%) | 48 | 12 (8% deliveries) | |
Lung infection since recovery (%) | 64 | 12 | |
Osteonecrosis (%) | 60 | 0 | |
Hyperlipidemia (%) | 68 | 40 | |
Cardiovascular abnormality (%) | 44 | 0 | |
Abnormal glucose metabolism (%) | 60 | 16 | |
Red blood cells in urine (%) | 33 | 4 | |
Urine protein (%) | 8 | 0 | |
Below normal range (%) | |||
Neutrophil ratio | 20 | 12 | |
Triiodothyronine | 8 | 0 | |
Above normal range (%) | |||
TGs | 44 | 16 | |
VLDL-C | 16 | 0 |
